and their comments regarding HIV infection as a risk factor for venous thromboembolism (VTE). This associa tion has been definitely established in a Danish populationbased study. 3 In Box 1 of our Review, 2 we identified that infectious diseases are associated with an increased risk of VTE, 4 but avoided detailing particu lar infectious agents. For example, acute Cytomegalovirus infection, which is far more common than HIV infection, doubles the risk of VTE. 5 Other wellestablished risk factors for VTE are Staphylococcus aureus infection 6 and active tuberculosis. 7 More broadly, in a large populationbased study, respiratory tract, urinary tract, skin, gastro intestinal, and bacteraemic infec tions diagnosed in the community or in hospital were associated with a 2.6fold to 3.3fold increased risk of VTE after adjustment for other factors. 8 As Bibas et al. correctly point out, ongoing oppor tunistic infections can further increase the risk of VTE in patients infected with HIV. 9 We agree that infections and inher ited thrombophilia might have a synergic
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effect on the risk of VTE, as demonstrated for pneumonia and factor V Leiden or pro thrombin G20210A. 10 However, no data are available on the interaction between HIV infection and thrombo philia on the risk of VTE. Therefore, the statement that patients who are infected with HIV and carry one of the common mild thrombophilia abnormal ities should be considered at higher risk of VTE than individuals who are not infected with HIV remains speculative. Considering that combined antiretroviral therapy might increase the risk of VTE, 3 we prefer not to cause unwarranted alarm in the 6-8% of patients with HIV who carry hetero zygous factor V Leiden or the prothrombin mutation with assumptions that are not evidencebased. 
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